Overview
Enlace Health provides an end-to-end, tech-enabled platform that helps payers, providers, and patients shift from fee-for-service to value-based care, with a focus on specialty care. Its platform includes the Opportunity Analyzer, which identifies areas for cost and quality improvement; the Program Builder for designing customized episodes of care and value-based payment models; and the Claims Administrator and Claims Payments modules to manage contracts, reconcile claims, and disburse funds. The company differs by offering an integrated, specialty-focused suite that covers analytics, program design, and payments in one system, supported by experienced leadership and significant funding. Its goal is to help clients design, manage, and scale value-based care programs that align financial incentives with patient outcomes and promote cost containment across payer–provider–patient ecosystems.
Work here?Claim your company
Simplify's take
What believers are saying
- Health Evolution listed Enlace as a partner in November 2026, widening executive distribution.
- September 2026 PCI episode analysis across 8,793 cases shows proprietary cost-variation insight.
- HITRUST r2 certification and the 2026 board addition support enterprise sales into payers.
What critics are saying
- Enlace still looks small, with roughly $104.5 million total funding against larger rivals.
- If CMS TEAM adoption slows after 2026, Enlace's specialty-care pitch loses urgency.
- Hospitals can internalize episode administration or choose incumbents, compressing Enlace's pipeline by 2027.
What makes Enlace Health unique
- Enlace bundles specialty analytics, program design, claims administration, and payments into one platform.
- Its 2025 CMS TEAM launch targets mandatory episode-based reimbursement, not optional pilot programs.
- Craig Samitt joined the board in April 2026, strengthening payer and clinical credibility.
Help us improve and share your feedback! Did you find this helpful?